Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Significant Decline in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,040,500 shares, a decrease of 11.3% from the March 31st total of 3,427,500 shares. Based on an average trading volume of 1,800 shares, the days-to-cover ratio is presently 1,689.2 days.

Genomma Lab Internacional Stock Performance

Shares of Genomma Lab Internacional stock remained flat at $0.92 during midday trading on Tuesday. Genomma Lab Internacional has a fifty-two week low of $0.79 and a fifty-two week high of $0.99. The business’s 50-day simple moving average is $0.88 and its 200 day simple moving average is $0.85.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.